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Résumé 
Un problème récurrent pour les sportifs réguliers concerne la récupération de leurs réserves de 
substrats entre leurs séances, et notamment ceux en glycogène musculaire. Celui-ci est un 
facteur limitant la performance d’endurance, et il a été postulé qu’il pourrait être économisé à 
l’effort en augmentant le métabolisme des lipides via leurs réserves locales sous forme de 
lipides intramyocellulaires (IMCL). Nos 5 athlètes volontaires ont suivi à tour de rôle les 
séquences suivantes : après un exercice déplétif de 2h30, consommation d’une diète 
isocalorique riche en graisses et fructose (FRU : 45% glucides dont 35% fructose, 47% lipides 
et 8% protéines) ou riche en graisses et glucose (GLU : 45% glucides dont 40% glucose, 47% 
lipides et 8% protéines) sous forme de repas liquides répétés durant 36 heures, avant un 
second exercice de 3h effectué le lendemain et suivi d’un effort mesurant la performance 
d’endurance.  
Notre hypothèse était que FRU augmenterait plus les IMCL que GLU tout en replétant le 
glycogène. La seconde hypothèse était que cela épargnerait le glycogène musculaire lors d’un 
exercice subséquent, aboutissant à une amélioration de la performance d’endurance.  
Les niveaux musculaires en glycogène et IMCL ont été mesurés par spectroscopie à résonance 
magnétique (1H-MRS) après l’effort initial, et suite au dernier repas liquide. Les échanges 
gazeux respiratoires, la glycémie, la lactatémie, les niveaux de triglycérides, acides gras libres 
et acide urique ont été mesurés lors de l’ingestion de 3 repas liquides, et le lendemain lors du 
deuxième effort sur ergomètre. 
Si FRU n’a pas augmenté le remplissage des IMCL par rapport à GLU (P=0.922), FRU a 
augmenté le glycogène musculaire 2.6 fois plus (P<0.05). Si FRU a effectivement augmenté 
lors de son ingestion les oxydations totales de glucides (P<0.05), tandis que la glycémie était 
mieux maîtrisée (P<0.01) et que la lactatémie était augmentée (P<0.001), les concentrations 
plasmatiques en triglycérides n’ont pas été modifiées par FRU comparé à GLU (P=0.166). Le 
lendemain, FRU a favorisé l’oxydation plus précoce des lipides lors de l’exercice prolongé 
(P<0.01) tandis que les oxydations glucidiques n’étaient pas modifiées (P=0.098) dans la 
durée. Une baisse de glycémie plus précoce a également été observée, expliquant peut-être 
l’absence d’amélioration de la performance d’endurance (P=0.134). 
En conclusion, les stocks en glycogène musculaire peuvent être augmentés en consommant 
une diète riche en fructose durant les 36 heures précédant un effort, mais cela n’aboutit pas à 
une amélioration de performance, peut-être car le contrôle hépatique de la glycémie est 
perturbé et ce, même chez des athlètes protégés des autres effets négatifs du fructose. 
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Introduction 
Glycogen as a performance limiting factor 
During prolonged (ie >5 min) exercise, skeletal muscle energy provision rely on oxidation of 
endogenous (i.e. intracellular stores) and exogenous (i.e. blood borne) substrate sources, 
mainly glucose and fatty acids. Other substrates, such as amino acids, lactate or ketone bodies 
may also be used for ATP production. There is a constant trade-off between glucose and fat as 
well as the proportion arising from endogenous and exogenous stores (Romijn et al., 1993) to 
ensure energy provision. Therefore, skeletal muscle endogenous stores, glycogen and 
intramyocellular triglycerides –or intramyocellular lipids (IMCL) –, are in competition in-
between and with blood-borne glucose and free fatty acids (FFA). Exercise intensity and 
duration are the main factors influencing substrate use (Figures 1 and 2), but other 
environmental factors, such as baseline levels of energy stores, gender, training status, 
temperature, etc., play a significant role. 
 
With increasing exercise intensity the proportions of fat and carbohydrate (CHO) used for 
contraction declines and increases, respectively. With the increased contribution of 
carbohydrates, and the small contribution of circulating glucose to skeletal muscle glucose 
oxidation (Figures 1 and 2) during exercise performed at 60% or more of maximal aerobic 
power (MAP), muscle glycogen (carbohydrate’s storage form: a branched polysaccharide) 
availability is considered to be a limiting factor. Typically, when glycogen levels become low, 
circulating glucose cannot match the demand, and exercise intensity cannot be maintained. 
For example, the resulting fatigue is well known among marathoners as the “hitting the wall” 
Figure 1: Substrate utilization depending on 
exercise intensity (Romijn et al., 1993) 
Figure 2: Substrate utilization at 60% VO2max 
depending on exercise duration (Romijn et al., 
1993) 
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phenomenon. This also occurs in many other aerobic sports, in which it is a limiting factor for 
endurance exercise performance. As a consequence, much research in the field of sport 
science has focused on developing strategies to delay glycogen depletion and hence 
exhaustion. First, several protocols aiming at raising total glycogen content over normal 
physiological levels have been explored, combining diet interventions with or without 
exercise training modifications. With success, as some protocols led to substantial 
improvements in aerobic performance (for review, see Ivy, 2001). 
  
Pre-competitive protocols could not only aim at maximizing glycogen levels before exercise, 
but also at diminishing glycogen use: increasing the contribution of any other substrate would 
lead to a sparing of glycogen in myocytes. Fat could potentially fulfill that purpose, because it 
contributes substantially to energy provision at exercise intensities up to 85% VO2max
1 
(Fig.1) and this is even increased by exercise duration (Fig.2). Precisely, conditions in which 
total fat use is increased coincide with that in which glycogen use declines. Then, it was 
hypothesized that increasing the availability of fatty acids to the mitochondria would allow 
decreasing the reliance on glycogen.  
 
Cellular fat molecular metabolism 
Blood-derived lipids are used by the cells in various manners depending on conditions (Figure 
3). They can cross the plasma membrane, then can be stored as IMCL for subsequent use or 
be directly oxidized for energy purposes. Circulating fat –in form of lipoproteins-bound 
particles- is processed by the lipoprotein lipase (LPL) complex at the blood-cell membrane 
interface. LPL catalyzes the hydrolysis of the triacylglycerol component of circulating fat 
particles, liberating free fatty acids (FFA). Importantly, LPL is regulated at transcriptional, 
posttranscriptional, and posttranslational levels in a tissue-specific manner (for review, see 
Wang and Eckel, 2009). For instance, its activity is increased in muscle cells by contraction 
but decreased by insulin. In the adipose tissue, insulin affects LPL activity in an opposite 
manner. Released FFA can then cross the sarcolemma membrane by the fatty acid transporter 
fat/CD36 (McFarlan et al., 2012). Holloway (et al., 2006) showed that CD36-mediated FA 
import is limited. Because of that, high circulating plasma FFA levels may not coincide with 
high intracellular FA pool. 
 
                                                     
1 For writing simplification, oxygen and carbon dioxide consumptions will be referred as VO2 and VCO2 
respectively, even if they represent gas flows and not volumes.  
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Once inside the cell, FFA are believed to form a common cytosolic pool from which some 
may be used or stored as lipid droplets named, in the case of skeletal muscle, intramyocellular 
lipids (IMCL) depending on cellular needs (Langfort et al., 2003).  
 
 
Fatty acids can be processed to acetyl-CoA that is able to enter the mitochondria where 
aerobic oxidation occurs to produce cellular energy. Importantly, the fat-derived ac-CoA 
mitochondrial entry by the carnitin-palmitoyl transferases (CPT) system is tightly regulated.  
Actually, it has been demonstrated that at rest, there is a constant competition between fatty 
acids and carbohydrates (CHO), with fat modulating CHO oxidation (Randle et al., 1963). 
During exercise however, as energy need raises, glycolytic flux appear to limit fat oxidation: 
with increasing intensity, it is proposed that the increasing glycolytic flux produces acetyl-
CoA in excess to the Krebs cycle capacity (Jeppesen and Kiens 2012). The proposed 
mechanism is that within mitochondria, acetyl-CoA binds to free carnitine, which limits 
Figure 3: Cellular fat metabolism keypoints (Kanaley et al., 2009) 
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carnitine availability that can be bound to fatty-acyl-CoA. This limits fatty-acyl-CoA 
movement across the mitochondrial membrane, and hence fat oxidation (Figure 4, Jeppesen 
and Kiens 2012).  
 
Figure 4: Schematic overview of a proposed interaction between fatty acids metabolism and 
glycolysis in skeletal muscle (Jeppesen and Kiens, 2012) 
 
Carbohydrates can then be viewed as leading on an energy switch in high energy needs 
conditions, while fat is mainly used at rest.  
 
At any time, IMCL content is dependent on the balance between synthesis (lipogenesis) and 
hydrolysis (lipolysis). Briefly, lipids esterification, or lipogenesis, is performed by adding 
FAs to a glycerol molecule, GPAT and DGAT believed to be intracellular regulatory enzymes 
in the process. GPAT and DGAT expression were shown being themselves regulated by 
hormones, insulin favoring it and glucagon diminishing it. 
 
The breakdown, or lipolysis, however, is believed to be regulated by HSL (hormone-sensitive 
lipase) that was found in skeletal muscle (Langfort et al., 1998). This enzyme is believed to be 
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the key regulator of lipolysis and its activation has been reported to be activated by 
catecholamines and/or muscle contraction (Langfort et al., 2003).  
 
Mechanisms implicated in particular intracellular FA fate are still not very clear, but several 
regulatory proteins, the lipid droplets physico-chemical properties and the particular 
properties of the FA themselves seem implicated into decision whether each FA subtype is 
stored in IMCL or recycled in the cytosolic pool. 
 
Because limitations on IMCL metabolism concern all mentioned regulating endpoints, as well 
as possible additional unidentified ones, the question whether IMCL form an important 
substrate source during exercise and how its utilization is regulated is still not fully elucidated. 
 
Various strategies were tried to adapt metabolic pathways toward an increase in IMCL 
oxidation, combining both endurance training and a high-fat diet. Such studies effectively 
resulted in an increased fatty acids oxidation (for review, see Burke et al., 2000). However, 
chronic high-fat diets had no effective improvement in subsequent endurance performance, 
comparing to high-carbohydrate diets (Erlenbusch et al., 2005). There were also side effects 
to chronic high-fat intake such as: reduction of glycogen content, difficulties to train hard, 
increased sympatho-adrenal activation, down regulation of glycogenesis and decreased mood 
state (Zehnder et al., 2006). All of these side effects may be linked to the lack of performance 
improvement. 
 
To benefit from the effects of augmented fat oxidation without the negative chronic effects, 
pre-competitive dietary protocols were proposed, and included a glycogen loading phase over 
a few days, followed by a specific high-fat intake the last day. Indeed, it was shown that 
depleted IMCL levels can be replenished within a day (Boesch et al., 1999, Décombaz et al., 
2000) and that IMCL are used during a subsequent exercise in proportion to their initial 
content (Zehnder et al., 2006). In this study, IMCL lipolysis increased while total 
carbohydrate and net fat oxidation rates were maintained, thereby resulting in a sparing of 
plasma FFA, but not of glycogen. Moreover, Costill et al. (1979) showed that pre-exercise 
elevated FFA decreased the carbohydrate oxidation during exercise and Zehnder et al. (2006) 
arrived to the same conclusion concerning elevated IMCL content. However, in both cases, no 
effect on performance was noticed. The conditions in which glycogen is the performance 
limiting factor and the mechanisms controlling its use are not fully elucidated.   
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Still, because FFA availability is somewhat low at the onset of exercise and increases with 
time, and because exercise, even in competitive settings such as cycling, may be performed at 
low to moderate intensity before high-intensity bursts where glycogen becomes a limiting 
factor, increasing IMCL content, and thereby FA availability for mitochondria may spare 
glycogen and improve exercise capacity/performance. 
 
Together, it means that, in fasted, low-insulin conditions, post-prandial lipids should be 
directed from whole body to muscle cells. Moreover, preceding contraction accelerates lipids 
intake into skeletal muscle cell. This would suggest that a specific short-term (24-36h) high-
fat protocol could aim at repleting selectively IMCL in skeletal muscle by limiting circulating 
insulin levels, together with a sufficient carbohydrate intake in order to increase endurance 
performance.  
 
A particular sugar 
Fructose, a simple sugar, has been 
intensively studied due to its 
particular metabolism. It is 
absorbed from the intestine via 
specific transporters (GLUT 5), 
before entering the bloodstream. 
Fructose metabolism markedly 
differs from that of glucose in that 
it is not metabolized in non-
hepatic tissues. Therefore, it is 
almost completely processed in 
the liver and plasma 
concentrations are very low. 
Whilst dietary glucose can be 
processed by almost all tissues, 
fructose can only enter 
hepatocytes cytosol. Here, both glucose and fructose can be converted to pyruvate. However, 
while glucose follows the glycolysis pathway that is regulated by insulin and cell energy 
status, fructose bypasses the main regulatory step (phosphofructokinase) and is rapidly 
converted to pyruvate (Cortez-Pinto et al., 1999). This quick metabolism coming from a rapid 
Figure 5: Metabolic fate of an oral fructose load (Tappy 
and Lê, 2010) 
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entry, the lack of negative feedback loops and independence on insulin, results in high 
pyruvate levels in hepatocytes following a fructose load. Pyruvate can then be used in various 
manners. Fructose-derived extra pyruvate carbons can be discharged to bloodstream by lactate 
conversion. These carbons can also newly synthetize glucose (neoglucogenesis). However, it 
was shown that the extra glucose produced by neoglucogenesis wasn’t delivered to 
bloodstream contrarily to lactate. This was shown to be due to compensatory hepatic 
glycogenolysis down regulation at rest (Tounian et al., 1994). This coupling, however, is lost 
during exercise due to hyperglucagonemia (Surmely et al., 1999).  
 
Pyruvate can also be oxidized through import in the hepatocytes mitochondria and Krebs 
cycle. It can as well be stored locally, either as hepatic glycogen, or following de novo 
lipogenesis pathway. Resulting intrahepatic cellular lipids pool forms the basis of VLDL-
bound triglycerides (Figure 5). 
 
As a result, fructose intake was reported to raise acutely blood lactate and lipoproteins-bound 
triglycerides levels, and to diminish the increase in glycaemia comparing to glucose. Tracer 
studies aiming at defining the different pathways proportions concluded that the vast majority 
of the fructose carbons were converted to glucose (50%), lactate (25%) and glycogen (>15%) 
(Figure 5). De novo lipogenesis seemed of quantitatively low importance (<1%), however this 
pathway seems responsible for suspected deleterious effects of fructose and such a percentage 
may underestimate the delayed in time conversion (for review, see Sun, 2012).      
 
Fructose is known to be less insulinemic than comparable amounts of glucose. Lower post-
prandial insulin levels result in a lower lipoprotein lipase activity in adipose tissue, 
diminishing blood lipids clearance. Any blood metabolite levels are determined by input 
(production) and output (clearance). As fructose raises hepatic lipid production while 
diminishing clearance, it was related to induce hyperlipidemia, even if its underlying 
mechanisms remain controversial. Sun (2012) reviewed not only de novo lipogenesis 
stimulation, but also possibly energy source shifting and lipid sparing effect. In any case, 
fructose-induced hyperlipidemia was implicated in the occurrence of several cardiovascular or 
metabolic diseases (for review, see Tappy and Lê, 2010).  
 
However, fructose has been commonly used by the sport beverages industry as combined 
fructose-glucose ingestion during exercise was found to enhance total carbohydrate oxidation 
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(Jentjens et al., 2004). Because of its fat metabolism enhancing role, fructose may also favor 
fat metabolism in myocytes. However, Lê et al. (2006) found no significant augmentation of 
IMCL content following two weeks of fructose overfeeding. As both the influences of high fat 
diets and physical activity were shown to influence IMCL and muscle glycogen stores 
(Zehnder et al., 2005), it is hypothesized in this study that preceding physical activity in 
combination with fructose may somehow interfere on IMCL metabolism.  
 
Aim of the study 
This work focused on the effects of fructose versus glucose on IMCL and glycogen 
replenishment between two exercise bouts. It was hypothesized that, after a prolonged 
exercise bout, a 36-hour high-fructose/high-fat diet would enhance IMCL content more than a 
high-glucose/high-fat diet. As a consequence, it was hypothesized that during the subsequent 
aerobic exercise, IMCL oxidation would rise, leading to a decrease in glycogen breakdown, 
possibly allowing better exercise performance. 
 
Furthermore, the aim of this study was to explore the feasibility of labeling IMCL stores with 
stable isotopes and to measure their oxidation non-invasively during exercise. MRS has been 
well documented as a non-invasive, patient friendly, reproductive method with a good 
correlation with other techniques for assessing skeletal muscle glycogen and IMCL contents 
(Schrauwen-Hinderling et al., 2006). Therefore, this study is a proof-of-concept study aiming 
at validating the use of stable isotopes to measure IMCL breakdown kinetics during exercise. 
 
Techniques 
Indirect calorimetry 
The term calorimetry refers to the science of measuring the heat of chemical or physical 
reactions. While direct calorimetry measures energy exchanges, they can also indirectly be 
measured by monitoring gas exchanges. Short, to be oxidized a substrate needs oxygen (O2) 
and produces carbon dioxide (CO2), water (H2O) and energy in various amounts. The indirect 
calorimetry is based on known stoichiometry of macronutrients’ oxidation, i.e. when a 
specific macronutrient is oxidized, a fixed amount of O2 is consumed and a fixed amount of 
CO2 is produced. Other assumptions include that consumption of O2 that is not linked to 
respiration is negligible, and that oxidative phosphorylation is not uncoupled. Considering 
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this, indirect calorimetry allows measurement of net substrate oxidation (Tappy and Schneiter, 
1997) both at rest and during exercise.  
 
In our study, at rest, briefly, the volunteer’s head was placed in an open-circuit canopy, which 
was constantly ventilated. As the indirect calorimeter measured the air flows with a turbine 
and the gas compositions (in/out of the canopy), it was possible to assess the gas flows: 
 
O2 consumption: VO2 [ml/min] = V (Fin O2 – Fout O2) 2 
CO2 production: VCO2 [ml/min] = V (Fout CO2 – Fin CO2) 
Respiratory quotient: RQ = VCO2 / VO2  
 
The VO2 and VCO2 values were then interpolated per time intervals to calculate 
macronutrients net oxidation rate. These rates were calculated using total O2 consumption, 
CO2 production and urinary nitrogen excretion (corresponding to proteins oxidation) using 
Weir’s equations (1949) corrected by Livesey and Elia (1988). Respiratory quotient for 
glucose, lipids and proteins were assumed as 1.0, 0.7 and 0.8 respectively. Net substrate 
oxidations were calculated as (Frayn 1983): 
 
Total lipid oxidation (LOX) [mg/min] = 1.67 VO2 – 1.67 VCO2 – 1.92 N 
Total carbohydrate oxidation (CHOX) [mg/min] = 4.55 VCO2 – 3.21 VO2 – 2.87 N 
Total protein oxidation (POX) [mg/min] = 6.25 N 
 
N: Nitrogen excretion [mg/min] was measured by urine collection throughout the tests. 
Energy expenditure was calculated using each macronutrient’s oxidation rates: 
 
EE [kcal/min] = 3.73 CHOX + 9.3 LOX + 4.1 POX 
 
During exercise, the measurement was slightly different as gas exchanges were measured with 
a mask coupled to a flow meter. Flow meter determined the ventilation rate and air flow 
direction, while a tube collected expired air to measure gas composition. Together, it was 
                                                     
2 With V being the ventilation rate (ml/min), Fin and Fout O2 and CO2 the inspired and 
expired fractions of oxygen and carbon dioxide, respectively. 
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possible to measure VCO2 and VO2 breath-by-breath. This allowed the assessment of the 
oxidation rates of carbohydrate and fat.  
 
Because of the normal physiological variation of gas exchanges and urine was collected 
throughout the test, obtained data were averaged over 30min intervals and summarized to 
obtain total oxidation values.  
 
Body impedance analysis (BIA) 
This technique is commonly used to measure body composition. Four electrodes were placed 
on the volunteer’s wrist (styloïd processus of ulna bone), hand (distal part of third 
metacarpal), ankle (medial part between inner and external malleolus) and foot (distal part of 
third metatarsus). A small electrical current circulated between electrodes as the volunteer had 
to rest in supine position. The electrical impedance was measured and it was used to estimate 
total body water. As the quantity of water is not the same between fat and fat-free masses, this 
technique is able to assess body fat-free mass and body fat mass. This is performed by 
measuring a single electric arc, and then using algorithms depending on age, height and 
weight for whole body distributions.  
  
Tracers- stable isotopes tracers 
Isotopes are defined as variations of neutrons number of an element (sharing same proton 
number), resulting in different atomic weights. With the example of carbon, depending on the 
number of neutrons, some are stable (carbon-12, carbon-13) and others are unstable 
(radioactive carbon-11, carbon-14). Although natural abundance of isotopes species is 
varying, it is assumed to be almost invariant in given conditions (Nier and Gulbransen, 1939). 
Particularly, if the molecule comprising the specific atom is modified, (f.eg. during metabolic 
reactions) it is still possible to trace atom’s fate. This is based on the assumption that the 
isotopic species of a same element are metabolized in the same fashion. The manipulated rare 
isotope specie is called the tracer, whereas the molecule comprising the most abundant 
isotope is called the tracee. The ratio tracer to tracee is called isotopic enrichment and can be 
measured. Particularly, as the isotopic enrichment of the ingested food is known, the isotopic 
enrichment of expired carbon dioxide allows calculating which part was oxidized while the 
remaining stayed in body.  
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Concerning lipid metabolism, tracers comprising stable isotopes can be used in diverse 
manners that are safe for subjects. For instance, we used stable isotopes for estimation of 
oxidation of exogenous fatty acids at rest and during exercise. Volunteers ingested 13carbon-
containing fatty acids, and expired 13CO2 in breath air was measured by isotopes-ratio mass 
spectrometry (IRMS).  
 
Briefly, IRMS is a specialization of mass spectrometry that measures the relative isotopic 
abundances in a given sample. The latter is processed before entering the mass spectrometer, 
separating atom of interest (carbon here) by chemical methods from similar weighting atoms. 
Then, the atomic specie of interest is ionized and resulting ions are accelerated. A magnetic 
field diverts them depending on atomic weight and a screen detects collisions, reflecting 
isotopic species proportions (isotopic enrichment).  
 
Magnetic resonance spectrometry (MRS) 
Also known as nuclear magnetic resonance (NMR) spectroscopy, this method can be used to 
characterize tissues. This technique is highly associated to magnetic resonance imaging. Both 
use a standard whole-body scanner. Using a magnetic field and varying frequency, MRS is 
able to measure resonance frequencies of various body molecules. In skeletal muscles, proton 
MRS (1H-MRS) can be used to measure IMCL (demonstrated by Boesch et al., 1997) and 
glycogen. In 1H-MRS, because water includes hydrogen atoms, a process called water 
suppression has to be performed by measuring the water signal, then removing it to assess 
lipids-associated protons signals in methylene (CH2) groups. Thus, this method quantifies the 
abundance of lipids in a tissue area, but not the type of lipids. Particularly, 1H-MRS is not 
able to distinguish between intra- and extra myocellular lipids (peaks of IMCL and EMCL 
partially overlap). Thus, in volunteers with a high EMCL content, IMCL value may be 
overestimated. To avoid this, the voxel can be moved in an area with less EMCL and, as this 
protocol included athletes, measurements should not have been enormously overestimated. 
 
Comparing to other IMCL measuring methods (electron microscopy, histochemistry, 
computed tomography, biochemical analysis or magnetic resonance imaging), MRS has 
numerous advantages: it is non-invasive, patient friendly and reproducible (coefficients of 
variation about 6% versus more than 12% in biopsies according to Boesch et al., 1997). MRS 
allows repeated measurements on identical muscle volumes, and is therefore especially 
interesting to monitor the effect of an intervention.  
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Glycogen quantification can be performed in a similar manner by 1H-MRS. Both isotopes 
allow relative measurements and, by comparison to assumed invariables peaks 
(phosphocreatine f.eg.), absolute quantification is possible, though laborious.  
 
Blood analyses 
Blood was collected on EDTA-coated tubes for measurement of free fatty acids, triglycerides, 
glucose, lactate, uric acid, total cholesterol, cortisol and insulin, as EDTA-trasylol-coated 
tubes were used concerning glucagon. After collection, blood was immediately centrifuged 
(10min, 3600g at 4°C) and plasma was aliquoted, then stored at -20°C until analyzes. Lab 
technicians performed the following analyzes. Briefly, lactate concentration was measured 
enzymatically by using kits from Boehringer (Boehringer Mannheim, Mannheim, Germany). 
Plasma glucose concentration was measured by the glucose oxidase method with a Beckman 
glucose analyzer II (Beckman Instruments, Fullerton, USA). Colorimetric methods were used 
to assess plasma concentrations of FFAs (kit from Wako Chemicals, Freiburg, Germany). 
Commercial radioimmunoassay kits were used for the determination of plasma cortisol, 
insulin and glucagon (Linco Research, St Charles, USA).   
 
Subjects and study conception 
Whole study design 
This was a randomized cross-over trial in 
which subjects were their own controls. 
Treatments order was randomly chosen 
and neither the subjects, nor the 
investigators were aware of allocation. 
The study was performed in Lausanne 
University and Hospital and in Bern 
Hospital. As illustrated in Figure 6, volunteers first came to a screening visit before being 
enrolled in the study. 
The trial began with a preliminary visit (V0), during which maximal aerobic capacity and 
anthropometric measurements were performed. To avoid training status variations, soon after 
that the volunteers began with experiment itself. They faced the two conditions in a row, 
respecting a  2-4 weeks’ washout interval in-between. Each condition consisted in two 
Figure 6: Whole study design 
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successive three-day periods of tests (first condition: V1, V2 and V3, and second condition: 
V4, V5 and V6).  
A food-controlled period lasting 2 days was set before each condition. Diet was weighted and 
provided to the volunteers for the two forthcoming days, and the morning of the first day of 
tests (V1 and V4). Menus included 55% carbohydrate (40% polysaccharides, 15% sugars), 
30% fat (10% saturated, 10% monounsaturated, 10% polyunsaturated) and 15% protein in 
isocaloric amounts, trying to avoid 13C and fructose-rich foods. Total calories amounts were 
calculated using anthropometric measurements of V0 (age, height, weight) with the Harris-
Benedict equation (Harris and Benedict, 1918). A correcting factor of 1.7 was then applied, 
considering this population’s usual high physical activity levels. 
In order to complete standardization of their metabolic status before the tests, volunteers were 
instructed to perform a two-hour, low intensity cycling training two days before V1 and V4, 
and then to refrain from physical exercise the day before tests periods.  
Three-day tests periods (Figure 7) were similar, except for the diet composition submitted to 
the volunteers on the first two days (V1-2 and V4-5): high-fructose versus high-glucose. On 
first testing day (V1 and V4), subjects reported to the lab at 1300, were instructed to void and 
were weighted. They performed a depleting exercise (2.5 hour at 50% MAP) on a cycle 
ergometer in order to lower their glycogen and IMCL stores. Décombaz et al. (2001) and 
Figure 7: Three-day tests periods 
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Vermathen et al.  (2012) showed decreases in IMCL and glycogen contents of 25-30% and 
40-45% respectively after comparable exercises in duration and intensity. Within 3h post-
exercise, IMCL and glycogen stores were measured by 1H-MRS in medium vastus of 
quadriceps muscle. Time interval between end of exercise and MRS was shortened 
maximally, trying to lower refilling by other organs’ stores. During that interval, calories 
intake was null and expenditure minimized in order to get depleted values of skeletal muscle 
stores.  
Following MRS measurement, a repletion period started using liquid shakes of known 
composition. That period lasted 24h, but covered 36h EE by adding the depletion plus MRS 
measurement time. Shakes were prepared in order to achieve 80% of theoretical EE, 
achieving a slight hypocaloric status of subjects:  Energy intake was set as 0.8 multiplied by: 
36h-energy expenditures (Harris-Benedict with factor 1.0) plus energy expenditure of the 
depleting exercise (2.5 hours at 50% MAP assuming a mechanic yield of 22.5%).  
In order to direct energy to depleted muscle cells, shakes were absorbed in equal amounts at 
eight different time points, the first three taking place on the first testing day (V1, V4) 
immediately after MRS in proximate time points. The last five shakes were ingested the day 
after (V2, V5). The two conditions differed in the sugar composition of the shakes: containing 
either a fructose/glucose 7:1 proportion3, or glucose alone. The macronutrients proportions in 
the shakes were: 45% carbohydrates (40% of known industrially purified pure glucose or 
fructose), 47% fat (17% saturated, 14% monounsaturated, 16% polyunsaturated) and 8% 
proteins. Labeled 13C-palmitate will be incorporated in tracer amounts only in next volunteers, 
and this is why it is not presented in our results.      
Repletion continued on second testing day (V2 and V5), and metabolic response to feeding 
was assessed (see below post-prandial testing section for details). IMCL and glycogen stores 
of vastus medialis of quadriceps muscle were again measured by MRS after completing the 
24h refilling repletion period. For compliance reasons, subjects were then provided a low-
lipid, small sandwich comprising white bread and jerked/dried meat (achieving a slight 
hypocaloric status: 90% of 36h-EE covered since run-in).   
                                                     
3 For writing simplification, high fructose-containing condition is referred as FRU, being opposed to GLU, even 
if 5% of the total calories consisted of glucose as well in FRU condition. Glucose adjunction was performed to 
enhance intestinal absorption of fructose (for review, see Latulippe and Skoog, 2011). 
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The last day of test periods (V3 and V6), subjects reported to the laboratory at 0700, being 
overnight fasted. Body composition was firstly measured, following what they underwent a 
metabolic testing (see below the so named section for details) to measure IMCL oxidation 
rates and blood metabolites kinetics both at rest and during exercise. Finally, endurance 
performance was assessed the same day by a simulated 20km time-trial protocol (see below 
time-trial section for details). 
Subjects 
A total of twelve endurance cycling trained males (cyclists and triathletes) with competitive 
experience will be enlisted in the study. The characteristics of the first five subjects having 
completed the study are presented in Table 1. All subjects had a cycling training history of at 
least 5many years including competitive status. Subjects were selected after a first informal 
meeting. All were aged 18-45 years old, having a body mass index (BMI) between 18 and 
25kg/m2 and in general good health, as assessed by a general health questionnaire and rest 
electrocardiogram examination. None of them was taking any medications, smoked, drank 
over 10g/day alcohol, had a history of cardiovascular, nor type 2 diabetes events, or was 
anemic. Before participation, all of the volunteers were fully informed on the risks associated 
with the study and its purpose, and they fulfilled a written consent. This protocol was 
effectuated with respect to Helsinki’s Declaration and was approved by the Ethics Committee 
of the Faculty of Biology and Medicine, University of Lausanne as an addendum to protocol 
451/11. 
 
Table 1: Study participants characteristics 
 N = 5 Mean SD 
Age [y] 30 10 
Height [cm] 180 7 
Weight [kg] 72 5.2 
Body fat [%] 16.9 1.5 
MAP [W] 376 28 
VO2max [l/min] 4.809 0.349 
VO2max/kg [ml*min-1*kg-1] 67.1 4.5 
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Preliminary visit (V0) 
Within two weeks of the beginning of the first testing period, subjects were weighted, 
measured for height and their peak oxygen consumption (VO2max, [ml*min
-1*kg-1]) and its 
associated power were measured. Briefly, weight was obtained to the nearest 0.1 kg with a 
Seca 708 electronic weighing scale, and height was measured to the nearest 0.1 cm with a 
Seca height scale, allowing calculating their body mass index (BMI).  
 
To measure maximal oxygen consumption (VO2max) and maximal aerobic power (MAP), an 
incremental test to exhaustion was performed on a cycle ergometer (Lode Excalibur Sport, 
Lode B.V., the Netherlands). Subjects started cycling at 60 W for 5 min, followed by 
incremental power steps of 35W every 3 min until exhaustion. Heart rate (HR) was 
continuously recorded by a Polar heart rate monitor (Polar Vantage NV, Kempele, Finland).  
At the end of each power steps, several parameters were measured: Subjects’ rate of perceived 
exhaustion was monitored using Borg’s scale. Drops of blood from the earlobe were collected 
after each step to measure lactate concentrations (Lactate Pro, Arkray,  Kyoto, Japan). MAP 
was calculated from the last completed step, plus the fraction of time cycled in the final non-
completed work rate multiplied by 35W. The obtained MAP was used to determine exercise 
intensity percentages used in further tests.  
 
Gas exchanges were monitored breath-by-breath by indirect calorimetry (Vmax, 
SensorMedics srl, Italy) throughout the VO2max testing with a mouthpiece. The volume 
sensor and gas analyzers were calibrated using a three liters syringe and variations of known 
gas compositions respectively. Oxygen uptake (VO2) was considered to be maximal 
(VO2max) when at least two of the three following criteria were met: 1) a leveling off of VO2 
with increasing workload (increase of no more than 2 ml*min-1*kg-1), 2) a HR within 10 
beats/min of predicted maximum (HR 220 minus age), and 3) a respiratory quotient exchange 
ratio (RQ=VCO2 / VO2) over 1.05 (Jentjens, 2005). VO2max was calculated as the average 
VO2 (ml*min
-1*kg-1) over the last 30 seconds of the test. The volunteer’s VO2max and MAP 
are also presented in Table 1. 
 
After a period of rest, subjects were familiarized to the time-trial (see the so-called section). It 
was reported that exercise reproducibility is accurate enough after a single familiarization 
time-trial (Laursen et al., 2003).  
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Post-prandial testing (V2 and V5) 
After fasting overnight, subjects reported at 0700 to the laboratory where they were asked to 
void and weighted. A catheter was then inserted into an antecubital vein (right arm) by which 
blood samples were collected. Trying to avoid homeostasis perturbation due to the catheter 
positioning, a period of 30min was respected before first values were collected. To obtain 
most relaxed resting values, subjects watched TV, laid in a bed during the whole 6h-test.  
Baseline expiratory air samples were collected in quadruplicate to assess expired air 13CO2 
isotopic enrichment and blood was drawn to measure plasma metabolites basal 
concentrations. 
Subjects were then asked to drink first shake, after what indirect calorimetry measurement 
was started for two hours. Every 30min, breath and blood samples were collected throughout 
the test as, to assess post-prandial response, volunteers were provided other shakes at 120 and 
240min to repeat three times a 2h-procedure shown in Figure 8. Indirect calorimetry was 
performed to assess resting EE, LOX and CHOX. POX was assessed by collecting total urine 
production during the test and measuring urea concentration. 
 
Figure 8: Post-prandial testing (V2 and V5) 
Metabolic testing (V3 and V6) 
The day after, being overnight fasted, volunteers reported at 0700 to the laboratory where they 
were again voided and weighted. Blood and air samples were collected in the same manner as 
the day before. First, resting metabolism was measured by indirect calorimetry. During this 
time, blood and air were collected respectively three and five times to standardize baseline 
resting values. 
After a 20min transition period, still fasted volunteers were asked to start pedaling constantly 
at 50% MAP during three hours as measurements were made every twenty minutes. That data 
collection comprised 5min of indirect calorimetry, blood and air samples. Hearth rate was 
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monitored during the whole exercise. After a 3h cycling period, the volunteers were provided 
a 65g carbohydrate-rich snack as they were allowed to recover during 20min before the time-
trial. 
Time-trial (V3 and V6) 
In order to assess performance, a ‘time-trial’ testing was organized. The volunteers had to 
complete as fast as possible an individualized work on ergometer. This work was calculated 
as the mechanical energy corresponding to 20km cycled at 85% of personal MAP at 
preferential pedaling frequency. Volunteers were isolated from distractions and no 
information of time, power nor pedaling rate was given. Time-trial duration, exercise intensity 
(as a percentage of MAP) and absolute power were collected as endurance performance 
indexes.  
 
Randomization 
Condition’s order were randomized for each volunteer and kept under key. Neither the 
volunteers, nor the investigator (until data analysis) were aware of it. Precisely, simple sugars, 
glucose (GLU) or Fructose to Glucose in a 7:1 proportion (FRU) were added in the shakes 
preparation by a different person than the investigators. Thus, it was a double-blind trial. 
 
Statistics 
Before statistical analysis, all variables were tested for normality using the Kolmogorov-
Smirnov test. Then, Student’s two-tailed paired t-tests were applied on single parameters. 
Time-evolving variables were analyzed for treatment (GLU compared with FRU) and time 
effects using a 2-way (time x condition) repeated-measures analysis of variance (ANOVA), 
followed, if applicable by Bonferroni post hoc test. Differences beyond 95% of confidence 
interval (P values lower than 0.05) were considered significant. All statistical operations were 
performed using Prism 5.0 (GraphPad Software, San Diego, USA). All data are presented as 
means ± SD. 
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Results 
1) Depleting exercise (V1 and V4) 
On run-in of the three-days testing period, the volunteers exercised during 150 min at 50% 
MAP to deplete quadriceps muscle glycogen and IMCL stores. Monitored mean heart rates 
were similar between GLU and FRU conditions (135 ± 8 vs. 134 ± 8 bpm, paired t-test: 
P=0.791). 
 
2) Medium vastus energy stores (V1-2 and V4-5) 
Quadriceps muscle IMCL contents were comparable between GLU and FRU conditions in 
depleted (4.85 ± 1.47 vs. 4.63 ± 1.78 mmol/kg ww, P=0.832), as well as in repleted state (8.27 
± 2.76 vs. 8.13 ± 2.96 mmol/kg ww, P=0.884). IMCL 24h repletion was effective in both 
conditions, although no treatment effect was detected between GLU and FRU respectively 
(Fig.8A: 3.42 ± 1.60 vs. 3.5 ± 1.49, 2-way ANOVA: treatment, P=0.922; time, P<0.01; 
interaction, P=0.950). Glycogen 24h recovery was higher in FRU as compared to GLU 
(Fig.8B: 0.12 ± 0.13 vs. 0.32 ± 0.04 a.u.4, 2-way ANOVA: treatment, P<0.05; time, P<0.01; 
interaction, P<0.05), although this difference may be due to initial glycogen content (1.33 ± 
0.13 vs. 0.94 ± 0.11 a.u., P<0.05) rather than final glycogen value (1.45 ± 0.23 vs. 1.26 ± 0.10 
a.u., P=0.201) in GLU and FRU respectively. See Table 2 for summary and Figure 9 for 
illustration. 
 
Figure 9: Mean augmentation of quadriceps muscle energy stores contents in response to 
ingestion of glucose (GLU) or fructose (FRU) containing shakes. For all variables, n=5. 
Analyses were performed by paired Student’s t-tests in all panels (A-B). A: P=0.984. B: 
P<0.05. Significant differences between GLU and FRU treatments: *P<0.05, **P<0.01 and 
***P<0.001 (Bonferroni post hoc test). Data are shown as means ± SD. 
                                                     
4 a.u. : Arbitrary Unit to creatine content, considered as stable. 
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Table 2: Repletion of myocellular stores (V1-2 & V4-5) 
Symbols: GLU, glucose alone condition; FRU, fructose-containing condition; SD, standard 
deviation; IMCL, intramyocellular lipids; ∆ IMCL, differences between depleted and repleted 
IMCL contents; ∆ Glycogen, differences between depleted and repleted glycogen contents T x 
T, Treatment x Time interaction. P values were obtained by paired Student’s t-tests for not 
evolving values and 2-way repeated-measures ANOVA for 24h repletion. Data are shown as 
means  ± SD. 
n = 4 GLU FRU P values 
Mean SD Mean SD Treatment Time T x T 
Depleted IMCL [mmol/kg ww] 4.85 1.47 4.63 1.78 0.832 - - 
Repleted IMCL [mmol/kg ww] 8.27 2.76 8.13 2.96 0.884 - - 
∆ IMCL [mmol/day/kg ww] 3.42 1.60 3.50 1.49 0.922 <0.01 0.950 
Depleted Glycogen [a.u.] 1.33 0.13 0.94 0.11 <0.05 - - 
Repleted Glycogen [a.u.] 1.45 0.23 1.26 0.10 0.201 - - 
∆ Glycogen [a.u.] 0.12 0.13 0.32 0.04 <0.05 <0.01 <0.05 
 
3) Post-prandial response to the diet (V2 and V5) 
At baseline, none of the fasting indirect calorimetry parameters differed between conditions 
(Student’s paired t-tests). Overall, whole-body lipid oxidation was 103.0 ± 17.6 vs. 87.0 ± 
29.0 mg/min (P=0.199) and protein oxidation 18.0 ± 2.8 vs. 17.3 ± 3.2 mg/min (P=0.750) 
were not different between GLU and FRU. However, carbohydrate oxidation was lower in 
GLU, as compared to FRU (101.4 ± 39.4 vs. 156.8 ± 70.9 mg/min; P<0.05), even if that 
difference was mostly imputed to first testing hour. Overall, this resulted in a comparable 
energy expenditure (EE: 1.42 ± 0.12 vs. 1.48 ± 0.20 kcal/min; P=0.607). Because of that 
increased CHOX, the mean RQ was augmented as well in FRU (0.78 ± 0.03 vs. 0.82 ± 0.05; 
P<0.05). Taken together, whole body oxidations were 67.9% lipids, 26.8% carbohydrates, 
5.2% proteins vs. 55.2% lipids, 39.9% carbohydrates, 4.8% proteins in GLU and FRU 
respectively.  
Interestingly, QR peaks following shakes ingestion did not appear at the same time between 
treatments (2-way ANOVA: T x T component: P<0.001). They seemed to happen earlier in 
FRU condition (Fig.10) and this may be due to differences in both LOX (P<0.01) and CHOX 
(P<0.001) in T x T interaction effect. See Figure 10 for LOX and CHOX kinetics illustration. 
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Figure 10: Mean postprandial 30min-averaged macronutrient oxidation rates in response to 
ingestion of glucose (GLU) or fructose (FRU) containing shakes at three successive time 
occurrences (T=0;120;240). For all variables, n=5. Analyses were performed by 2-way 
repeated ANOVA in both panels. A: P=0.199 for treatment, P<0.01 for time, P<0.01 for 
interaction. B: P<0.05 for treatment, P<0.001 for time, P<0.001 for interaction. Significant 
differences between GLU and FRU treatments at certain time points: *P<0.05, **P<0.01 and 
***P<0.001 (Bonferroni post hoc test). Data are shown as means ± SD. 
 
Concerning plasma metabolites, at baseline, triglycerides (0.39 ± 0.08 vs. 0.41 ± 0.07, 
P=0.145), glucose (4.61 ± 0.13 vs. 4.80 ± 0.25, P=0.060) and uric acid (0.40 ± 0.05 vs. 0.39 ± 
0.04, P=0.121) were similar between GLU and FRU. Free fatty acids (0.50 ± 0.16 vs. 0.34 ± 
0.09, P<0.05) and lactate (0.68 ± 0.10 vs. 0.55 ± 0.09, P=0.051) were higher in GLU as 
compared to FRU. 
In both conditions plasma concentrations of free fatty acids (P<0.001), triglycerides 
(P<0.001), glucose (P<0.001), and lactate (P<0.001) were significantly increased with time. 
However, no significant effect of time was found for uric acid concentrations (P=0.077).  
As compared to GLU, changes over time of plasma triglycerides (Fig.11A) and lactate 
(Fig.11D) were increased in FRU. On the other hand, plasma concentrations of free fatty acids 
(Fig.11B), glucose (Fig.11C) and uric acid (Fig.11E) were not modified as compared to GLU. 
Combined effect of fructose and time (2-way ANOVA: Treatment x Time parameter) resulted 
in statistical differences between GLU and FRU conditions for free fatty acids (P<0.01), 
triglycerides (P<0.01), glucose (P<0.01) and lactate (P<0.001), while uric acid response was 
similar (P=0.122). See Figure 11 for illustration and Table 3 for summary of the postprandial 
test.  
Fructose effect on IMCL replenishment and utilization                          January 2013 – Robin Rosset 
- 25 - 
 
 
Figure 11: Mean plasma metabolites concentrations in response to ingestion of glucose 
(GLU) or fructose (FRU) containing shakes. For all variables, n=5. Analyses were performed 
by 2-way repeated ANOVA in all panels (A-E). A: P<0.01 for treatment, P<0.001 for time, 
P<0.01 for interaction. B: P=0.769 for treatment, P<0.001 for time, P<0.01 for interaction. C: 
P<0.01 for treatment, P<0.001 for time, P<0.01 for interaction. D: P<0.001 for treatment, 
P<0.001 for time, P<0.001 for interaction. D: P=0.978 for treatment, P=0.077 for time, 
P=0.122 for interaction. Significant differences between GLU and FRU treatments at certain 
time points: *P<0.05, **P<0.01 and ***P<0.001 (Bonferroni post hoc test). Data are shown 
as means ± SDs. 
 
Table 3: Postprandial metabolic characteristics (V2 & V5) 
Symbols: GLU, glucose alone condition; FRU, fructose-containing condition; SD, standard 
deviation; VO2, oxygen consumption; VCO2, carbon dioxide production; T x T, Treatment x 
Time interaction. P values were obtained by Student’s t-tests for baseline values and 2-way 
repeated-measures ANOVA for time evolving variables.  Data are shown as means ± SD. 
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n = 5 
GLU FRU P values 
Duration [min] 360 - 360 - - - - 
Meals time [min] 0 ; 120 ; 240 0 ; 120 ; 240 - - - 
Indirect calorimetry Mean SD Mean SD Treatment Time T x T 
VO2 [l/min] 0.297 0.025 0.305 0.033 0.701 <0.01 0.794 
VCO2 [l/min] 0.233 0.021 0.251 0.03 0.295 <0.001 0.087 
Total lipid oxidation [mg/min] 103.0 17.6 87.0 29.0 0.199 <0.01 <0.01 
Total carbohydrate oxidation [mg/min] 101.4 39.4 156.8 70.9 <0.05 <0.001 <0.001 
Total protein oxidation [mg/min] 18.0 2.8 17.3 3.2 0.750 0.453 0.453 
Energy expenditure [kcal/min] 1.42 0.12 1.48 0.20 0.607 <0.001 0.790 
Lipids (% energy) 67.9 - 55.2 - - - - 
Carbohydrates (% energy) 26.8 - 39.9 - - - - 
Proteins (% energy) 5.2 - 4.8 - - - - 
Respiratory quotient 0.78 0.03 0.82 0.05 <0.05 <0.01 <0.001 
Plasma metabolites Mean SD Mean SD Treatment Time T x T 
Triglycerides: baseline [mmol/l] 0.39 0.08 0.41 0.07 0.290 - - 
Triglycerides : evolution [mmol/l] 0.51 0.15 0.66 0.25 0.166 <0.001 <0.01 
Free fatty acids: baseline [mmol/l] 0.50 0.16 0.34 0.09 0.090 - - 
Free fatty acids: evolution [mmol/l] 0.24 0.13 0.24 0.10 0.769 <0.001 <0.01 
Glucose: baseline [mmol/l] 4.61 0.13 4.80 0.25 0.119 - - 
Glucose: evolution [mmol/l] 6.48 1.13 5.54 0.55 <0.01 <0.001 <0.01 
Lactate: baseline [mmol/l] 0.68 0.10 0.55 0.09 0.102 - - 
Lactate: evolution [mmol/l] 0.74 0.13 1.50 0.50 <0.001 <0.001 <0.001 
Uric acid [mmol/l] 0.40 0.05 0.39 0.04 0.242 - - 
Uric acid: evolution [mmol/l] 0.40 0.05 0.40 0.05 0.978 0.077 0.122 
 
 
 
4) Metabolic testing (V3 and V6) 
At rest, VO2, VCO2, RQ, and net substrate oxidation were comparable between GLU and 
FRU (Table 4). Fasting concentrations of plasma free fatty acids (0.526 ± 0.143 vs. 0.594 ± 
0.269 mmol/l, P=0.303), triglycerides (0.565 ± 0.116 vs. 0.569 ± 0.156 mmol/l, P=0.549), 
glucose (4.996 ± 0.553 vs. 5.028 ± 0.299 mmol/l, P=0.276) and uric acid (0.398 ± 0.061 vs. 
0.390 ± 0.046 mmol/l, P=0.488) did not differ between GLU and FRU conditions. Resting 
plasma lactate concentration was however higher in GLU as compared to FRU (0.681 ± 0.065 
vs. 0.579 ± 0.072, P<0.01) (Table 4). 
As expected, EE as well as total substrate oxidation rates increased significantly (p<0.001) 
with exercise, but did not differ between conditions (p for treatment effect =NS, Table 4). 
Mean heart rate did also not statistically differ between treatments (P=0.273) although it was 
slightly higher (146 ± 6 vs. 142 ± 6 bpm) in GLU condition. Interestingly, there was a 
significant interaction between treatment and time for net lipid oxidation, suggesting different 
kinetics of lipid oxidation rates between conditions (Fig.12). During the first, second and third 
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exercising hours, lipid oxidation represented 44.2 vs. 46.6%, 47.4 vs. 50.5% and 51.1 vs. 50.6 
% of total energy expenditure in GLU and FRU, respectively, while carbohydrate oxidation 
decreased with time and represented 55.6 vs. 53.2%, 52.4 vs 49.3% and 48.7 vs. 49.2% of 
total energy expenditure in GLU and FRU respectively.  Because POX was obtained through 
whole day urine collection, intra-exercise time effect was not analyzable. Overally, lipids, 
carbohydrates and proteins provided respectively 47.5%, 52.3%  and 0.2% of total energy 
expenditure during the exercise bout,  corresponding to 2673 kcal in GLU condition. In FRU 
49.2% of EE was accounted for lipid, 50.6% for carbohydrate and 0.2% for protein oxidation, 
averaging 2666 kcal. See Figure 12 for LOX and CHOX kinetics and Table 4 for summary of 
other parameters. 
 
 
Figure 12: Mean 20min-averaged fasted macronutrient oxidation rates one day after ingestion 
of glucose (GLU) or fructose (FRU). For both variables, n=5. Analyses were performed by 2-
way repeated ANOVA in both panels. A: P=0.670 for treatment, P<0.01 for time, P<0.01 for 
interaction. B: P=0.756 for treatment, P<0.05 for time, P=0.092 for interaction. Data are 
shown as means ± SD. 
 
 
All plasma metabolites were significantly (p<0.05) changed by exercise. Interestingly, even if 
no significant change was found between GLU and FRU with regard to the integrated 
response of plasma metabolites (Table 4), plasma lactate concentrations exhibited a different 
pattern (p for interaction <0.001), as shown in Fig 13D).  
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Figure 13: Mean plasma metabolites concentrations, the day after ingestion of glucose (GLU) 
or fructose (FRU). Subjects firstly rested during one our (T≤60min), then exercised (50% 
MAP) for 3h (60<T≤240min). For all variables, n=5. Analyses were performed by 2-way 
repeated ANOVA in all panels (A-E), considering mean resting values (0<T≤60min) as 
baseline. A: P=0.941 for treatment, P<0.001 for time, P=0.984 for interaction. B: P=0.147 for 
treatment, P<0.001 for time, P=0.183 for interaction. C: P=0.256 for treatment, P<0.001 for 
time, P=0.729 for interaction. D: P=0.524 for treatment, P<0.001 for time, P<0.001 for 
interaction. E: P=0.824 for treatment, P<0.01 for time, P=0.763 for interaction. Significant 
differences between GLU and FRU treatments: *P<0.05, **P<0.01 and ***P<0.001 
(Bonferroni post hoc test). Data are shown as means ± SD. 
 
 
 
Fructose effect on IMCL replenishment and utilization                          January 2013 – Robin Rosset 
- 29 - 
 
With respect to kinetics, plasmatic concentrations of triglycerides and free fatty acids were 
continuously raised (TG: T=240; 1.198 ± 0.210 vs. 1.237 ± 0.127; FFA: T=240; 1.198 ± 
0.268 vs. 1.465 ± 0.109) in GLU and FRU respectively. 
 
Glucose concentration however, firstly peaked soon after the onset of exercise (T=80; 6.164 ± 
1.200 vs. 5.602 ± 0.797) above resting mean values (+1.168 vs. +0.574), then constantly 
diminished until the end of exercise (T=240; 4.484 ± 0.784 vs. 3.875 ± 0.849) in GLU and 
FRU respectively. Maximal values were correlated (R2 =0.92) to minimal, end-exercise, 
values. 
Plasma lactate also peaked soon after the onset of exercise (T=80; 1.246 ± 0.184 vs. 0.900 ± 
0.265) above resting values (+0.565 vs. +0.321) in both GLU and FRU. Exercise effect then 
decreased lactate concentration reaching minimal values (1.038 ± 0.193 vs. 0.804 ± 0.316) at 
different time points (180 vs. 160) for GLU and FRU respectively. Lactate concentration then 
rose again in both conditions until the end of exercise (T=240; 1.288 ± 0.377 vs. 1.633 ± 
0.390). See Table 4 for summary of whole metabolic testing. Results of insulin, glucagon and 
cortisol dosages are not known yet. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4: Day after metabolic characteristics at rest and during moderate exercise (V3 & V6) 
Symbols: GLU, glucose alone condition; FRU, fructose-containing condition; VO2, oxygen 
consumption; VCO2, carbon dioxide production; MAP, maximal aerobic power; SD, standard 
deviation; T x T, Treatment x Time interaction. P values were obtained by Student’s t-tests for 
baseline values and 2-way repeated-measures ANOVA for time evolving variables. Data are 
shown as means ± SD. 
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n = 5 
GLU FRU P values 
Rest Mean SD Mean SD Treatment Time T x T 
Duration [min] 60 - 60 - - - - 
   Indirect calorimetry Mean SD Mean SD Treatment Time T x T 
VO2 [l/min] 0.274 0.020 0.268 0.022 0.437 - - 
VCO2 [l/min] 0.209 0.016 0.201 0.017 0.261 - - 
Total lipid oxidation [mg/min] 108.5 16.6 110.0 16.7 0.745 - - 
Total carbohydrate oxidation [mg/min] 66.0 34.0 52.8 32.7 0.116 - - 
Total protein oxidation [mg/min] 6.9 2.3 7.3 2.0 0.812 - - 
Energy expenditure [kcal/min] 1.31 0.10 1.28 0.10 0.399 - - 
Lipids (% energy) 78.6 - 81.8 - - - - 
Carbohydrates (% energy) 19.2 - 15.8 - - - - 
Proteins (% energy) 2.2 - 2.4 - - - - 
Respiratory quotient 0.76 0.03 0.75 0.03 0.205 -   
   Plasma metabolites Mean SD Mean SD Treatment Time T x T 
Free fatty acids [mmol/l] 0.54 0.14 0.56 0.27 0.303 - - 
Triglycerides [mmol/l] 0.61 0.11 0.59 0.15 0.549 - - 
Glucose [mmol/l] 4.98 0.51 4.93 0.28 0.276 - - 
Lactate [mmol/l] 0.67 0.08 0.56 0.09 <0.01 - - 
Uric acid [mmol/l] 0.39 0.06 0.37 0.05 0.512 - - 
                
Exercise Mean SD Mean SD Treatment Time T x T 
Duration [min] 180 - 180 - - - - 
Set power (50% MAP) [W] 188 13 188 13 - - - 
Mean heart rate [bpm] 146 6 142 6 0.215 <0.001 0.949 
   Indirect calorimetry Mean SD Mean SD Treatment Time T x T 
VO2 [l/min] 3.135 0.110 3.099 0.177 0.659 <0.01 0.798 
VCO2 [l/min] 2.658 0.107 2.627 0.178 0.737 0.865 0.997 
Total lipid oxidation [mg/min] 758.2 117.9 783.2 120.4 0.670 <0.001 <0.01 
Total carbohydrate oxidation [mg/min] 2083.4 297.8 2009.1 363.1 0.756 <0.05 0.092 
Total protein oxidation [mg/min] 6.9 2.3 7.3 2.0 0.812 1.000 1.000 
Energy expenditure [kcal/min] 14.85 0.48 14.81 0.90 0.902 0.075 0.779 
Lipids (% energy) 47.5 - 49.2 - - - - 
Carbohydrates (% energy) 52.3 - 50.6 - - - - 
Proteins (% energy) 0.2 - 0.2 - - - - 
Respiratory quotient 0.85 0.02 0.85 0.02 0.919 <0.001 0.184 
   Plasma metabolites Mean SD Mean SD Treatment Time T x T 
Free fatty acids [mmol/l] 0.70 0.29 0.81 0.35 0.147 <0.001 0.183 
Triglycerides [mmol/l] 0.88 0.27 0.88 0.28 0.941 <0.001 0.984 
Glucose [mmol/l] 5.32 0.87 4.86 0.75 0.256 <0.001 0.729 
Lactate [mmol/l] 1.02 0.29 0.90 0.41 0.524 <0.001 <0.001 
Uric acid [mmol/l] 0.41 0.06 0.40 0.05 0.824 <0.01 0.763 
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4.3) Endurance performance (V3 and V6)   
Finally, endurance exercise performance was assessed by a time-trial protocol in which 
subjects had to complete an individualized work on ergocycle as fast as possible. No 
significant difference was observed with regard to work completion time (36:38 ± 2:35 vs. 
37:19 ± 1:28 min; P=0.157) that can also be expressed as average power (267 ± 21 vs. 257 ± 
20 W; P=0.150) or %MAP intensity (71.1 ± 4.8 vs. 68.4 ± 2.6) between GLU and FRU 
respectively. Time-trial mean heart rate difference (169 ± 4 vs. 166 ± 7; P=0.141) was also 
not different between conditions. See Table 5 for summary. 
 
Table 5: Performance assessment (V3 & V6) 
Symbols: GLU, glucose alone condition; FRU, fructose-containing condition; SD, standard 
deviation; P values were obtained by paired Student’s t-tests. Data are shown as means ± SD. 
n = 4 GLU FRU P values 
Mean SD Mean SD Treatment 
Mechanical work [kJ] 574 38 574 38 - 
Time [min] 36:38 02:35 37:19 01:28 0.157 
Average power [W] 267 21 257 20 0.150 
Intensity (% MAP) 71.1 4.8 68.4 2.6 0.134 
Mean heart rate [bpm] 169 4 166 7 0.141 
 
 
 
Discussion 
This study indicates that a post-exercise, high-fructose high-fat diet does not replenish more 
IMCL levels than does an iso-energetic high-glucose high-fat diet. Although not enhancing 
pre-exercise IMCL levels, and opposite to our expectations, our study indicates that a high-
fructose diet may increase skeletal muscle glycogen more than does a high-fructose diet. 
 
The effects of the diet composition in exercise recovery and next bout preparation have been 
intensively studied (for review, see Hawley et al., 2007 or Burke et al., 2011). Previous 
studies focussed on high glucose intakes and their ability to increase skeletal muscle glycogen 
within a few hours (Ivy et al, 1998, Jentjens et al., 2003). To our knowledge, if such diets 
(high-simple carbohydrates, high-fat, low protein) have been already tested on skeletal muscle 
energy stores dynamics, it is the first time that the particular role of fructose is tested. On the 
opposite, if the particular effects of fructose during or immediately before exercise are well 
known, few data exist on influence of fructose ingested the day before exercise. Therefore, 
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this study represents one of the first work in which fructose is used toward a fat adaptation 
strategy.  
 
Myocellular energy stores  
Our feeding protocol resulted in no change in 24h repletion rates of IMCL after fructose, but 
an enhanced repletion of glycogen comparing to glucose alone as directly measured by 1H-
MRS.  
 
It was assumed that the lipogenic effects of fructose feeding and the low insulin levels 
associated to fructose intake would drive to an increase in circulating TG (Lê et al, 2006; 
2009; Lê and Tappy, 2010) and a higher activity of skeletal muscle LPL, thereby leading to an 
increase in IMCL. Because fructose intake was spread over 36 hours only, it may be that 
fructose-induced de novo lipogenesis was not stimulated enough to induce a significant 
increase in circulating VLDL-TG, thereby preventing a further increase in IMCL levels as 
compared to the GLU condition. Our diminished TG response might be responsible for that 
low IMCL repletion, and is consistent with observations that physical activity prevents 
fructose-induced dyslipidemia (Egli et al., in revision, 2013). These results may indicate that 
in addition to an acute effect of exercise, chronic exercise may also prevent ectopic fat 
deposition, as shown earlier in our laboratory (Egli et al., in revision, 2013). Actually fructose 
is highly consumed among exercising athletes, partly because of its ability to raise total 
carbohydrate oxidation and intestinal absorption during exercise. As this highly exposed 
population doesn’t develop on the long term suspected health-concerning effects of fructose, 
Johnson et al. (2010) concluded that they may be protected. Then, as Burstein et al. (1984) 
showed that insulin receptors number is modulated by physical training, this could possibly 
explain that “protection”.  Our measures on highly aerobic trained individuals are in line to 
such considerations, and therefore the lack of fructose-induced hypertriglyceridemia could be 
explained by a protective mechanism due to chronic physical activity. This is further 
supported by the fact that numerous studies performed with less important fructose doses than 
ours (about 3g/kg per day) resulted in hypertriglyceridemia (f.eg. Bantle et al., 2000). 
 
IMCL appeared to be higher the first day subjects were tested, irrespective of treatment order 
(5.51 ± 1.87 vs. 3.97 ± 1.40 mmol/kg ww; P<0.05). It may be that for some reason the 
conditions’ facing order was of importance. The reason of this effect is unknown, and may 
still be related to the fact that the randomization was unbalanced in the five first subjects (i.e. 
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four faced GLU and then FRU vs. only one faced FRU and then GLU). Moreover, IMCL 
absolute contents after repletion on first faced condition were still higher than on second 
condition, although this did not reach significance (8.87 ± 3.52 vs. 7.53 ± 2.81 mmol/kg ww; 
P=0.056) while treatments still resulted in no difference. Considering that the depleting 
exercise was performed within the same mean heart rates ranges independently on order or 
treatment, it is possible that, for some reason, volunteers presented themselves on second 
testing period with lower basal IMCL levels. 
 
Concerning glycogen, its repletion was most effective in FRU. This was quite unexpected and 
in contradiction to previous work. Ivy et al. (1998) determined that glucose or glucose 
polymers were the most effective for replenishment of muscle glycogen. They also noticed 
the importance of calories intake partitioning, concluding that continuous high insulin levels 
induced by glucose allowed a higher glycogen synthesis. Fructose, being less insulin 
stimulating, was mostly beneficial for the replenishment of liver glycogen (Conlee, Lawler 
and Ross, 1987). Glycogen synthase, the key-regulating enzyme controlling glycogen 
synthesis, has been showed being stimulated by insulin or previous contraction (Nielsen et al., 
2004). Jentjens and Jeukendrup (2003), however, hypothesized that carbohydrate availability 
was the main limiting factor for glycogen synthesis. Because in our results glycaemia 
remained lower with fructose in the postprandial state, it could be expected that glycogen 
synthesis would be lowered in fructose condition. Because fructose increases less glycaemia 
than glucose, it also prevents insulin stimulation of glycolysis and oxidation. Then, glycogen 
breakdown may have been lowered in the postprandial state in the same time as synthesis was 
diminished. As glycogen content can be assumed being in constant balance between synthesis 
and breakdown, a diminution of both components induced by low insulin levels could still 
result in the overall higher net gain observed in fructose condition.  
 
However, Jentjens and Jeukendrup (2003) showed that low muscle glycogen concentration 
can be a potent regulator of glycogen synthase, while breakdown can be stimulated by high 
contents by direct binding to glycogen phosphorylase (Johnson et al., 1992). Because our 
subjects faced glycogen repletion with lower initial glycogen contents in FRU, synthesis was 
locally enhanced while breakdown was diminished and may also explain this discrepancy.  
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Fructose postprandial metabolism 
Our study also gave the opportunity to verify several traditional effects of fructose feeding 
(for review, see Sun 2012). Soon after ingestion, it effectively induced hyperlactatemia, 
diminished the glycemic peaks, and increased total carbohydrate oxidation that occurred 
earlier following the shakes.  
Uric acid is produced during the breakdown of purines, and fructose-induced raised plasmatic 
uric acid concentrations (hyperuricemia) were associated to cardiometabolic diseases 
(Johnson et al., 2007). The proposed mechanism was a drop in liver cellular ATP due to 
fructose metabolism, which in turn could induces AMP degradation and raises plasma and 
urine uric acid concentrations. Our study, however, didn’t result in any change in plasma uric 
acid concentrations. Wang et al. (2012) performed a meta-analysis on current knowledge 
concerning fructose-induced hyperuricemia. He concluded that while fructose overfeeding 
induced hyperuricemia, isocaloric fructose amounts did not increase plasma concentration of 
uric acid. He also concluded that non-diabetic patients were less exposed, moreover if the 
duration of fructose feeding was short. Our experiment, performed with a short time isocaloric 
fructose feeding on non-diabetic athletes, corroborate to these conclusions.   
 
Day after fasting resting consequences 
To our knowledge, only one study focused on the 24h effect impact of fructose on several 
metabolites following an acute fructose load. In that study, Teff (et al., 2009) also reported 
day after fasting metabolites values. Interestingly, the only fasting metabolite modified with 
fructose was plasma lactate that was decreased in their study as observed in ours. To explain 
this, the authors referred to Carmona and Freedland (1989) who associated lactate 
concentration to liver lipogenic activity. These authors propose that fructose depletes ATP in 
hepatocytes, resulting in SIRT-1 mediated activation of pyruvate dehydrogenase. In turn, 
acetyl-CoA levels rise, leading to an increase in lipogenic precursor availability. Therefore, it 
is possible that in our study the lower day after lactate fasting concentration could be 
explained by some compensatory mechanism occurring during the night following fructose 
ingestion, and that this mechanism involved an overnight decrease in liver lipogenesis. 
 
Contrarily to previous results (Bantle et al., 2000), we didn’t observe higher fasting 
triglycerides levels in fructose condition. As subjects were measured initially the day before, 
being fasted after 3/8 shakes, we can compare their fasted concentrations after 3/8 shakes and 
after 8/8 shakes on day of metabolic testing. In that order, both diets, however, increased 
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fasting triglycerides concentrations with increasing number of shakes. This has to be 
explained by our high fat diet composition (47%) in both conditions, by a possible protective 
effect of chronic physical activity or by the low duration of fructose exposure.  
 
Exercise metabolism 
Exercise allows the specific study of skeletal muscle metabolism, which represents the vast 
majority of energy expenditure in such conditions. Because opposite to glucose, fructose does 
not inhibit fat metabolism and oxidation, it is probable that much of its effect observable the 
day after should be similar to those observed after a high fat protocol and be especially visible 
during exercise. Therefore, much of our results can be compared to the study of Zehnder et al. 
(2006), which investigated the effects of a 36h high fat hypercaloric diet and their effects the 
day after on a subsequent 3h, 50% MAP continuous exercise performed by trained athletes, 
while they measured IMCL contents before and after exercise.  
 
Our results show no differences in total macronutrients oxidations, or whole body energy 
expenditure. This may signify that such a short-term change in the diet does not result in a 
change in substrate selection system. However, accordingly to Zehnder et al. (2006) our data 
indicate a trend toward higher total lipid oxidation during the first part of exercise in fructose 
condition that was no more present in the last hour. Zehnder et al. (2006) and Sacchetti et al. 
(2002) postulated that this initial higher lipid oxidation was due to IMCL utilization, which 
was proportional to initial content and decreased with exercise time. 
 
Interestingly, while Zehnder et al. (2006) observed that total fat utilization was enhanced only 
during the first exercising hour, they also noticed that it was correlated with participants’ 
aerobic capacity. Then, this confirms previous work on fat oxidation that is raised in athletes 
comparing to sedentary subjects (for review, see Kelley, 2005). As a result, highly trained 
athletes would more benefit from such fat adaptation protocols by increasing their lipid 
oxidation percentages during a longer exercising time.  
 
At that point, our fructose loading diet may seem interesting because of increased fat 
oxidation during the initial two exercising hours. However, it was also marked by the negative 
counterpart: lower glycemic values. Traditionally, at the onset of exercise, catecholamines are 
secreted via sympatho-adrenal stimulation via the fight-or-flight response (Bracha, 2004), 
resulting in an increased and decreased glucagon and insulin secretion, respectively. Then, 
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these hormones are responsible for increased liver glucose output while the exercising 
muscles increase their glucose uptake due to contraction. Depending on exercise intensity, 
muscle uptake overpasses limited liver glucose production, and glycaemia falls with time (for 
review, see Suh, Paik and Jacobs, 2007). 
 
Interestingly, our results show a trend to a lower glycaemia at the onset of exercise in fructose 
condition. Therefore, liver glucose output function may have been impaired by our high 
fructose, high fat diet, despite the documented effects of fructose enhancing liver glycogen 
(Décombaz et al., 2011). It is possible that this was due to decreased catecholamines in 
response to fructose, as this was already reported by Da Silva-Grigoletto et al. (2010).  
 
Our results further seem to confirm previous studies showing that fructose decreases 
exercising mean heart rate. Because heart rate is modulated by the autonomous nervous 
system (Glick and Braunwald, 1965), including its sympathetic component, it is possible that 
the possible diminution in catecholamines was responsible for heart rate diminution in 
fructose condition.  
 
Finally, volunteers reported hypoglycemia symptoms in both conditions. We can then suppose 
that muscular blood glucose uptake remained stable during exercise between conditions 
(Jeukendrup et al., 1999), and that our 3h/50% MAP exercise tested low glycemic response 
during the last hour.  
 
Interestingly, because lactate concentrations remained  steady during the first two exercising 
hours and then raised dramatically (Fig.13D), it can be hypothesized that gluconeogenesis 
from lactate may have been increased by fructose ingestion the day before, as it was already 
reported in exercising subjects ingesting fructose (Lecoultre et al., 2010). In our study, it is 
possible that fructose caused an increase in liver gluconeogenesis that was still enhanced the 
day after. Supposing this, it would explain our diminution in resting lactatemia in fructose 
condition. As expected, during exercise, lactate concentration arose in both conditions 
because of the muscles increased production. The liver gluconeogenesis was again supposed 
more active in fructose condition, as lactate concentrations remained lower. However, at the 
end of the exercise the marked difference in curves may be explained by the lowered 
glycemic values in FRU more than GLU, as low blood glucose was reported to raise lactate 
concentration (Medalle et al., 1971).  
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In fact, probably both lowered glycemic values and already maximized gluconeogenesis could 
explain the higher lactatemia in last exercising hour of fructose condition. In absence of direct 
flux measurements, this remains highly speculative, but interestingly all volunteers reported 
effectively more hypoglycemia symptoms during the last exercising hour of fructose 
condition and one volunteer had to drop out at that time.  
 
Plasma FFA were raised during exercise in both conditions, but there was a trend toward 
higher levels in fructose condition, especially marked during the last hour (Figure 13B). As 
plasma free fatty acids concentration represents a balance between adipose tissue lipolysis and 
exercising skeletal muscle uptake, one or both components can be responsible for these 
differences. While Romijn et al. (1995) showed that the muscle free fatty acids relay is 
constant or increased with exercise duration, lipolysis was shown to be effectively less 
repressed by low insulin (Yen and Steinmetz, 1972) or blood glucose (Frizzell et al., 1988) 
levels. As written before, fructose is known to induce lower insulin concentration. Then, 
persistent lower insulin levels resulting from FRU may have result in less repressed lipolysis 
during the whole exercise, while lower blood glucose may have been responsible for the last 
exercise hour differential lipolysis stimulation between treatments. Both fructose-induced 
lower insulinemia and lower glycaemia may have been responsible for the tendency to 
increased FFA concentration throughout the test. 
 
Sondergaard et al. (2011) showed that total triglycerides concentration falls during exercise in 
parallel to VLDL-TG production, assuming this subtype being responsible for the overall fall. 
On the other side, Magkos et al. (2008) showed that acute endurance exercise did not result in 
modifications of VLDL-TG kinetics. In both cases, acute exercise resulted in 
hypotriglyceridemia. However, in our data, plasma triglycerides levels rise similarly in both 
conditions. Because simple sugars were shown to increase day after triglyceridemia, it is not 
surprising that both diets induced the same profile the day after, furthermore because of the 
high fat content (47%) of both diets.  
 
As a summary, fructose may have favored lipid oxidation during the first two hours of 
exercise. This time was also marked by possible increased hepatic lactate clearance for 
gluconeogenetic purpose. However, on the counterpart, fructose seemed to diminish hepatic 
flexibility to exercise, and this may have induced an earlier glycemic fall. At that point our 
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data, however, do not provide any further information concerning the muscle glycogen and 
IMCL particular use during exercise. It is probable that at the times in which glycemic 
concentrations were low, volunteers had highly depleted muscle glycogen and IMCL as well. 
To test that, subjects were provided carbohydrate-rich food to raise blood glucose, as the 
following time-trial aimed to test muscle glycogen stores state according to their limitative 
role for performance in such conditions. 
 
Performance 
It is widely accepted that under most conditions glycogen appears to be limiting performance. 
Even if fructose repleted more stores, feeding values were maximized in glucose-only 
condition. Tentative to correlate maximal glycogen values to time-trial performance failed, 
despite normalization of data that were subtracted of familiarization intensity. Thereby, it is 
possible that in our study design glycogen was not the limiting factor for performance, or that 
the number of participants was too restrictive. A power analysis was run with actual time-trial 
intensity mean difference and SD and estimated that 12 subjects should be enough to reach 
significance (power 0.80). Therefore, any firm conclusion cannot be drawn yet. 
 
 
Conclusion 
Whereas both of our high-simple sugars/high-fat effectively enhanced both IMCL and 
glycogen contents, fructose did not increase IMCL content but surprisingly enhanced 
glycogen repletion, although this may be due to lower initial glycogen contents or a possible 
carry over effect. Much of the reported health-concerning fructose effects on postprandial 
metabolism were attenuated by the highly trained status of our volunteers. 
 
The following day, fructose did not result in significant modifications of fuel selection during 
exercise, although fat relay tended to increase. These possible advantaging effects during 
exercise were however counterbalanced by lower blood glucose concentrations, possibly 
limiting performance. 
 
Importantly, one major limiting factor of this study for now consists in the limited number of 
subjects. The insufficient number of observations may be responsible for both Type I and II 
errors, and this also induced a dysbalance in conditions facing order. To avoid carry over 
Fructose effect on IMCL replenishment and utilization                          January 2013 – Robin Rosset 
- 39 - 
 
effect, trials traditionally are randomized to assume an independency from faced conditions 
order. Because of the low actual number of subjects, our randomization resulted in 80% of the 
subjects facing GLU condition before FRU (75% concerning MRS measurements). The 
independence of observations then could not be ensured, resulting in a possible important 
bias. However, as this represents a time-scheduled MSc work, and because our study will 
continue and include further volunteers, a first insight of the future results, even if statistically 
incorrect, was presented and discussed above.  
 
For future perspective, it would be interesting to test a combined diet enriched in fructose and 
amino acids, as these latter have been reported to increase glucagon secretion (Assan et al., 
1977). Increased glucagon in turn was shown to enhance muscle LPL activity while 
diminishing adipose tissue lipoprotein lipase activity in the post-absorptive state (Wang and 
Eckel, 2009). Then, our diet would have replete more selectively IMCL than adipocytes. 
Furthermore, supposing that its concentration stayed elevated the day after, glucagon could 
have possibly helped liver glucose output during exercise in fructose condition, in turn 
limiting the observed glycemic fall, possibly responsible for our volunteers’ hypoglycemia 
during the last exercising hour. 
 
In any case, with our current protocol, the future use of 13C labeled palmitate will allow 
quantification of the oxidized fraction of dietary shakes and, thereby an estimation of IMCL 
oxidation. Therefore it will be possible to estimate IMCL and FFA contributions to fat fuel 
and compare the obtained data to Zehnder et al. (2006) values after high-fat feeding. 
 
From a personal point of view, this work represented my Masters of Science thesis. This study 
might seem little productive considering that my master lasted almost one year. To me, it is 
worth to be mentioned that I was first involved in another study protocol (effects of fructose 
on lactate kinetics) and second, that I have been involved in designing the study, submitting it 
to the Institutional Review Board, established the current protocol, scheduled the agenda and 
recruited the volunteers. All these procedures are time consuming but may not appear as a 
result in this manuscript.  
 
As I took much pleasure in Luc Tappy’s laboratory, and as I learned a lot during the whole 
year, I want to take the opportunity to thank every lab team member.   
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Especially, thanks a lot to Leonie Egli and Virgile Lecoultre for their whole year follow up 
with great, constant patience and helpful advices and to Philippe Schneiter and Luc Tappy for 
having giving me the opportunity to work on one of my subjects of particular interest. 
 
I also take the opportunity to render thanks to the volunteers that kindly accepted to give 
blood and sweat for this study. 
 
Thank you for reading, that’s all folks.  
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